1. EPIX Therapuetics designs and manufactures a catheter-based, temperature-controlled cardiac ablation system for patients with irregular heartbeats and atrial fibrillation.
2. When completed, the acquisition will expand Medtronic’s cardiac ablation portfolio to offer physicians a comprehensive suite of tools to treat patients with cardiac arrhythmias.
3. The acquisition is expected to close in Medtronic’s fourth quarter, which runs Jan. 26 to April 26.
More articles on devices and implants:
DePuy Synthes releases femoral neck fixation solution: 4 things to know
ZAP Surgical launches radiosurgery platform at Barrow Brain and Spine: 3 details
X-Bolt hip fracture device receives FDA approval: 4 insights
